Pembrolizumab induced-C3 glomerulonephritis and RBC cast nephropathy: a case report

BACKGROUND: Immune checkpoint inhibitors (ICIs) are increasingly being used in the treatment of several cancers. Pembrolizumab is an anti-programmed cell death-1 (anti-PD-1) monoclonal antibody that is approved for the treatment of metastatic non-small cell lung cancer (NSCLC). Pembrolizumab-associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zhi, Xu, Huan, Gou, Shenju, Wu, Hongyan, Hu, Zhangxue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210450/
https://www.ncbi.nlm.nih.gov/pubmed/37226096
http://dx.doi.org/10.1186/s12882-023-03202-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210450/
https://www.ncbi.nlm.nih.gov/pubmed/37226096
http://dx.doi.org/10.1186/s12882-023-03202-5

Ejemplares similares